Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:32 pm Sale |
2024-12-31 | 13G | Candel Therapeutics, Inc. CADL |
Northpond Ventures, LP | 0 0.000% |
-1,935,215 (Position Closed) |
Filing History |
| 2025-02-14 4:14 pm Purchase |
2024-12-31 | 13G | Candel Therapeutics, Inc. CADL |
Baker Bros. Advisors LP | 2,981,983 6.800% |
2,981,983 (New Position) |
Filing History |
| 2025-02-07 4:09 pm Sale |
2024-12-31 | 13G | Candel Therapeutics, Inc. CADL |
CVI Investments, Inc. | 0 0.000% |
-2,350,000 (Position Closed) |
Filing History |
| 2025-02-07 10:18 am Purchase |
2025-01-31 | 13G | Candel Therapeutics, Inc. CADL |
FMR CORP | 6,318,721 15.000% |
2,395,122 (+61.04%) |
Filing History |
| 2025-02-07 10:03 am Purchase |
2024-12-31 | 13G | Candel Therapeutics, Inc. CADL |
FMR CORP | 3,923,599 9.300% |
3,186,003 (+431.94%) |
Filing History |
| 2024-12-17 12:30 pm Purchase |
2024-12-13 | 13G | Candel Therapeutics, Inc. CADL |
CVI Investments, Inc. | 2,350,000 5.600% |
2,350,000 (New Position) |
Filing History |
| 2023-02-09 09:59 am Sale |
2023-02-09 | 13G | Candel Therapeutics, Inc. CADL |
FMR CORP | 737,596 2.552% |
-1,525,246 (-67.40%) |
Filing History |
| 2022-02-14 4:40 pm Purchase |
2021-12-31 | 13G | Candel Therapeutics, Inc. CADL |
Northpond Ventures, LP | 1,935,215 6.700% |
1,935,215 (New Position) |
Filing History |
| 2022-02-14 4:38 pm Purchase |
2021-07-29 | 13D | Candel Therapeutics, Inc. CADL |
Manning Paul B | 4,073,316 13.600% |
4,073,316 (New Position) |
Filing History |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Candel Therapeutics, Inc. CADL |
FMR CORP | 2,262,842 7.887% |
2,262,842 (New Position) |
Filing History |